| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Acutus Medical, Inc.
13G/A
AFIB · 005111109
|
0.1% |
2/17/2026
Event 7/9/2025
|
||||
| Advent Life Sciences LLP | 0% | |||||
| Advent Life Sciences Fund I LP | 0% | |||||
| Shahzad Malik | 0.1% | |||||
|
Aura Biosciences, Inc.
13G/A
AURA · 05153U107
|
3.3% |
2/17/2026
Event 2/13/2026
|
||||
| Advent Life Sciences LLP | 3.3% | |||||
| Advent Life Sciences Fund I LP | 3.3% | |||||
| Rajesh Parekh, Ph.D. | 3.3% | |||||
| Advent Life Sciences Fund III LP | 3.3% | |||||
| ALS III Carry and Co-Invest LP | 3.3% | |||||
| Advent-Harrington Impact Fund LP | 3.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.